These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4459005)

  • 1. [Research on the fibrinolytic effects developed in vivo from 7-(2-[pyrid(3)yl-methylamino]ethyl) theophylline nicotinate. Preliminary note].
    Preliminare N
    Clin Ter; 1974 Nov; 71(4):321-33. PubMed ID: 4459005
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinogen turnover during the treatment with xantinol nicotinate.
    Cultrera G; Giarola P; Gibelli A; Baldoni E; Cuttin S; Galetti G; Serenth'a P
    Arzneimittelforschung; 1971 Jul; 21(7):954-7. PubMed ID: 5109508
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects on the human fibrinolytic system of prolonged intravenous infusion of high doses of Complamin (xantinol nicotinate).
    Bouvier CA; Berthoud S
    Helv Med Acta; 1968 Mar; 34(2):170-86. PubMed ID: 4232105
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cerebral circulation during hyperbaric oxygenation. Effects of 3-(methyl-hydroxyethylamino)-2-hydroxypropyl theophylline nicotinate. Preliminary note].
    Albano G; Scaglione GC; Burruano G
    Boll Soc Ital Biol Sper; 1970 Mar; 46(5):269-72. PubMed ID: 5457925
    [No Abstract]   [Full Text] [Related]  

  • 5. [Kinin liberation by xantinol nicotinate?].
    Seidel G; Wentz U
    Arzneimittelforschung; 1972 Jun; 22(6):1012-3. PubMed ID: 5068347
    [No Abstract]   [Full Text] [Related]  

  • 6. [Isolation and characterization of metabolites of 7-/2-(3-pyridylmethylamino)ethyl/theophylline nicotinate (Teonicon) in the rat and human urine].
    Pitrè D
    Farmaco Prat; 1974 Jan; 29(1):46-60. PubMed ID: 4455522
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of xanthinol nicotinate on the isolated perfused lungs].
    Husemann B
    Arzneimittelforschung; 1970 Aug; 20(8):1070-1. PubMed ID: 5536505
    [No Abstract]   [Full Text] [Related]  

  • 8. Fibrinogen turnover and drugs acting on fibrinolysis.
    De Nicola P
    Acta Univ Carol Med Monogr; 1972; 52():25-31. PubMed ID: 4544612
    [No Abstract]   [Full Text] [Related]  

  • 9. [Potential cardiotonics. 9. Synthesis and cardiovascular effects of 2-(pyrid-3-yl)-methylamino-, 2-(3-amino-pyrazolidino)- and 2-hetarylamino-substituted 3-cyan-5-(pyrid-4-yl)-pyridines].
    Roloff B; Schäfer J; Rumler A; Hagen V; Hagen A
    Pharmazie; 1989 Dec; 44(12):859-60. PubMed ID: 2635323
    [No Abstract]   [Full Text] [Related]  

  • 10. [Contribution to the study of internal temperatures in subjects with arterial diseases with obliterating evolution. I. Effects of sodium nicotinate, theophylline-ethylenediamine and theophylline nicotinate].
    Blasi A; Licciardello M
    Boll Soc Ital Cardiol; 1966; 11(4):1111-5. PubMed ID: 5992024
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes in fibrinolysis after administration of theophylline nicotinate].
    Locatelli R; Centonza D; Bregani P; Esposito R
    Haematologica; 1967; 52(2):132-42. PubMed ID: 4976133
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood-aqueous barrier changes during activation of fibrinolysis in plasma].
    Rudobielski R
    Klin Oczna; 1974 Feb; 44(2):129-33. PubMed ID: 4453093
    [No Abstract]   [Full Text] [Related]  

  • 13. A study of the mechanism of fibrinolytic system activation by nicotinate in patients with liver cirrhosis.
    Prokopowicz J; Gabryelewicz S; Wolosowicz N; Szalaj W; Merkiel K; Mielech H; Langiewicz J
    Mater Med Pol; 1976; 8(1):43-7. PubMed ID: 1263583
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical and instrumental observations on the hemodynamic activity of a new drug: 7-(2-(3-pyridyl-methylamino)-ethyl)-theophylline nicotinate].
    Jovino R; Renda A
    Minerva Cardioangiol; 1971 Dec; 19(12):709-18. PubMed ID: 5129037
    [No Abstract]   [Full Text] [Related]  

  • 15. [Variations in fibrinolytic activity and fibrinogen caused by xanthinol nicotinate in cases of diabetes mellitus with peripheral vascular lesions].
    Ipbüker A; Bayer H
    Turk Tip Cemiy Mecm; 1969 Apr; 35(4):236-46. PubMed ID: 5810400
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative studies on the influence of Provasan, Complamine, Sadamine, A-100 and Clofibrat on the behaviour of some lipid fractions of plasma in experimental animals.
    Sulowska Z
    Mater Med Pol; 1974; 6(2):102-6. PubMed ID: 4431240
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action mechanism of nicotinic acid on fibrinolysis in vitro and in vivo].
    Andreenko GV; Migalina LA
    Vopr Med Khim; 1971; 17(4):423-7. PubMed ID: 5317629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Action of Sadamin, Polfa].
    Lukjan H; Bielawiec M; Bogdanikowa B; Kiersnowska B; Korfel B; Dowzyk W
    Pol Tyg Lek; 1972 May; 27(20):739-40. PubMed ID: 5029663
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the effects of oral treatment with vaso-active preparations on the EEG].
    Steinbach M
    Med Klin; 1965 Oct; 60(42):1701-4. PubMed ID: 5867184
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of a nicotinic acid derivative on the radiation induced mitosis inhibition of Ehrlic ascites tumor cells].
    Kaufmann H; Piaszek L; Tiemann W; Bartholomä HJ
    Arzneimittelforschung; 1968 Dec; 18(12):1579-82. PubMed ID: 5756256
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.